X4 Pharmaceuticals (XFOR) Revenue Growth (1y) (2025)

X4 Pharmaceuticals (XFOR) Revenue Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.39 Bn 467.60 Bn 1.35 Bn 35.46%
5 Vertex Pharmaceuticals 122.08 Bn 114.83 Bn 2.59 Bn 7.82%
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn 19.04%
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn 64.03%
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 96.43%
10 X4 Pharmaceuticals 167.69 Mn -49.36 Mn 2.20 Mn 79.08%

Historic Data

Download Data
DateValue
Dec 31, 2025 79.08%
Sep 30, 2025 215.18%
Jun 30, 2025 250.44%